A Study to Evaluate Efficacy, Safety and Tolerability of a Medication in Patients With Amyotrophic Lateral Sclerosis (ALS)
The purpose of this study is to investigate a new therapy for the improvement of skeletal muscle function in conditions associated with muscle weakness or fatigue such as Amyotrophic Lateral Sclerosis (ALS). Participants will receive the study drug or a placebo.
- Approximately 7 study visits over 18 weeks
- Participants will take a study drug or a placebo
- Visits will consist of questionnaires, medical exams, muscle strength tests, blood draws, urine collection, an an electrocardiogram (ECG)
- Diagnosis of ALS (Amyotrophic Lateral Sclerosis)
Can be done from home
KeywordsAmyotrophic lateral sclerosis (ALS), Neurology, Neuromuscular Disorders, Motor neuron disease, Lou Gehrig disease
Principal InvestigatorJames Wymer, MD
Begin a new search for other research studies
Studies listed on this site have been approved by a UF Institutional Review Board (IRB), which works to ensure the welfare and rights of research participants as required by federal regulations. Study listings are provided by the UF Clinical and Translational Science Institute in collaboration with UF research teams and the UF IRBs.